Does ERIBULIN Cause Metastases to bone marrow? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Metastases to bone marrow have been filed in association with ERIBULIN (eribulin mesylate). This represents 0.2% of all adverse event reports for ERIBULIN.
10
Reports of Metastases to bone marrow with ERIBULIN
0.2%
of all ERIBULIN reports
0
Deaths
10
Hospitalizations
How Dangerous Is Metastases to bone marrow From ERIBULIN?
Of the 10 reports, 10 (100.0%) required hospitalization.
Is Metastases to bone marrow Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERIBULIN. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does ERIBULIN Cause?
Neutropenia (675)
Malignant neoplasm progression (594)
Myelosuppression (520)
Febrile neutropenia (448)
Neutrophil count decreased (294)
Neuropathy peripheral (290)
White blood cell count decreased (289)
Pyrexia (275)
Disease progression (211)
Fatigue (209)
What Other Drugs Cause Metastases to bone marrow?
CYCLOPHOSPHAMIDE (65)
DOXORUBICIN (40)
CYTARABINE (36)
CARBOPLATIN (35)
ZOLEDRONIC ACID (32)
ETOPOSIDE (31)
OXALIPLATIN (30)
RIBOCICLIB (29)
RITUXIMAB (29)
VINCRISTINE (28)
Which ERIBULIN Alternatives Have Lower Metastases to bone marrow Risk?
ERIBULIN vs ERLOTINIB
ERIBULIN vs ERTAPENEM
ERIBULIN vs ERTUGLIFLOZIN PIDOLATE
ERIBULIN vs ERYTHROMYCIN
ERIBULIN vs ERYTHROMYCIN ETHYLSUCCINATE